Guidance for market authorization requirements for COVID-19 drugs: Overview (French, HTML)

View metadata and access the original French HTML file: Guidance for market authorization requirements for COVID-19 drugs: Overview.

Format

HTML

Access

file-only

Publisher-reported update

2022-07-28

This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.

Access original file